ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Free Cash Flow
ADC Therapeutics SA
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Free Cash Flow
$-139.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Free Cash Flow
CHf-61.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Free Cash Flow
$-272.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Free Cash Flow
CHf13.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Free Cash Flow
CHf-886.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Free Cash Flow
CHf-7.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Free Cash Flow?
Free Cash Flow
-139.1m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Free Cash Flow amounts to -139.1m USD.
What is ADC Therapeutics SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-2%
Over the last year, the Free Cash Flow growth was 0%. The average annual Free Cash Flow growth rates for ADC Therapeutics SA have been 7% over the past three years , -2% over the past five years .